Patent · US Active

Angiotensin II receptor antagonists

US8252825B2 · kind B2 · utility

0Cited by
1References
3Claims
0Family size

Assignees

Inventors

Key dates

Filing dateNov 21, 2008
Grant dateAug 28, 2012
Priority date—
Expiry dateNov 21, 2028

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P43/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A compound having the structurewherein R is an angiotensin receptor antagonist active group, and Y is provided that when Y is —C(O)(CH2)2R5, then R is

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.